Skip to content Provide accessibility feedback
By using the Volpara website you accept our use of cookies. Here’s our privacy statement.
Breast Health
For Patients
Customer Stories
Contact us
Magnifying glass Search

#1 AI tool for automated breast density

Meet Volpara Scorecard.

The objective TruDensity® algorithm in Volpara® Scorecard™ is proven to reduce reader variability.

TruDensity automatically assesses the volumetric breast density percentage (VBD%) of each mammogram on a continuous scale—whether a patient’s density is a “high B” or a “low C”—to evaluate everyone on the dense, non-dense threshold more precisely.

Make the right call

Patients on the border

Nearly 75% of patients will be assessed in either the B or C density categories.

Remove subjectivity

Visual assessment has variability

Research has shown that radiologists who assess breast density visually assign density categories inconsistently. In a blind study, two experts agreed on a BI-RADS density category about 65% of the time.

Careful review of mammogram results letter
  • We have found Volpara to decrease inter- and intra-observer variation in breast density determination, thereby optimizing the care of our patients.

    – Dr. Kathy Schilling, Lynn Women’s Health Institute at Boca Raton Regional Hospital, Baptist Health

  • We have 12 radiologists and needed to take subjectivity out of our density reading because when patients come back next year, they will most likely have a different radiologist. We wanted consistency. Volpara was the clear choice and the radiologists have come to rely on it.

    – Diana Iglewski, Southtowns Radiology

Volpara Scorecard by the numbers

16.5 m+

women annually have had their breast density assessed by Volpara's software

The only

breast density assessment validated for use with the TC8 risk model


peer-reviewed papers and research abstracts featuring Volpara


You might be interested in...

10 Mar 2023

FDA Breast Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement

Information on breast composition from the DENSE trial
29 Mar 2021

DENSE Trial demonstrates huge reduction of breast cancer false positives